 |
Alilou’s research focuses on applying computer vision and machine learning techniques for automatic analysis of chest CT scans. The resulting technology aids radiologists and pathologists with automatic detection, quantification, diagnosis, and treatment response prediction of lung cancer and other lung diseases. |
 |
Human musculoskeletal modeling and development of control systems for rehabilitation of individuals with spinal cord injury and other balance disorders. Design of rehabilitation devices for physically challenged individuals.
|
 |
Hamid Charkhar, Ph.D. Dr. Charkhkar’s research focuses on developing neuroprostheses for people with limb loss or neuromuscoskeletal impairments. He aims to restore the lost or compromised sensorimotor function through neurotechnology which will result in increased stability, reduced risk of falls, and improved gait. |
 |
Dr. Graczyk’s research aims to understand the neural coding of somatosensation and to restore and augment sensory capabilities through neural stimulation in humans. Dr. Graczyk’s lab combines clinical studies, computational neuroscience, cognitive neuroscience, and artificial intelligence to examine the perception and utilization of sensory information for translation to persons both with and without sensory deficits. |
 |
Dr Janowczyk’s research focuses on applying machine learning and computer vision algorithms to digital pathology images. The resulting computational models aid pathologists in many common tasks, such as disease detection, grading, and the prediction of prognosis and therapy response. |
 |
Dr Lu’s research focuses on developing novel computational tools for identifying sub-visual image features from medical images and utilizing these features for disease classification, grading and prognosis in the context of breast cancer, head&neck cancer, and lung cancer.
|
 |
Building novel computational tools and machine learning models for characterization, diagnosis and prognosis of cancer on imaging.
|
 |
Development of targeted imaging agents for detection and imaged-guided surgery of prostate cancer. Preclinical evaluation of PSMA-targeted theranostic agents for photodynamic therapy of prostate cancer.
|
